Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy-Reference-Cited by-同舟云学术

Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy

Published:2023-11-07 Issue:12 Volume:23 Page:1233-1248
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Mashkani Baratali¹^ORCID,Jalili Nik Mohammad¹^ORCID,Rezaee Seyed Abdolrahim²^ORCID,Boostani Reza³

Affiliation:

1. Department of clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2. Inflammation and Inflammatory Diseases division, Immunology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3. Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2023.2272639

Reference272 articles.

1. Human T-lymphotropic virus 1: recent knowledge about an ancient infection

2. An HTLV-I Vaccine: Why, How, for Whom?

3. Reducing the global burden of HTLV-1 infection: An agenda for research and action

4. Update on Neurological Manifestations of HTLV-1 Infection

5. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into human T‐lymphotropic virus type‐1 (HTLV‐1) pathogenesis‐host interactions in the manifestation of HTLV‐1‐associated myelopathy/tropical spastic paraparesis;Reviews in Medical Virology;2024-06-27

2. Multicenter Cross-Sectional Study of HTLV-1 Seroprevalence and Associated Risk Factors in Brazil;2024